Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Learn what retirement accounts you should use at 50. Choosing wisely can secure your financial freedom.
25,328 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A strategic BTC sale and easing ETF inflows pushed Bitcoin to a two-month low. This article breaks down what happened...
An AI-driven forecast in June 2026 warns of potential further weakness for XRP, signaling price targets that could un...
Tesla's China Sales Just Jumped 22% in May, ending a slump. This article breaks down what's behind the rebound, wheth...
Two giant asset managers closed a record private credit financing to accelerate Anthropic's compute. Here’s what that...
Nasdaq’s CFO argues that AI is a leadership issue, not a back-office project. With 650 institutions using its AI-powe...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
Microsoft is not shrinking its ambitions. In this deep dive, we explore how the tech giant aims to reset its gaming d...
Google Gemini AI projects a sharp, liquidity-driven Bitcoin rally to as high as $150,000 by the end of 2026, undersco...
This article dives into why this dividend stock's moat offers unparalleled stability for long-term investors. Discove...
As ICE activity rises in 2026, HR teams rely on three critical documents that decide what they may or must not do dur...
Bitcoin holds in the high-$70k range as AI stocks push higher, leaving investors weighing two very different paths. T...